Showing results (281-290 of 339) with videos related to
Sort By:
Pageof 34
Cancer Letters|October 2, 2022
TGF-β signaling networks in the tumor microenvironmentMax Kam-Kwan Chan, Jeff Yat-Fai Chung, Philip Chiu-Tsun Tang, et al.Epilepsy & Behavior : E&B|September 28, 2025
A pilot study of inter-regional phase amplitude coupling as comorbid depression biomarker in temporal lobe epilepsyAndy Ho Wing Chan, Muhammad A Parvaz, Riaz B Shaik, et al.Annals of Surgery|September 19, 2013
Randomized double-blinded prospective trial of fibrin sealant spray versus mechanical stapling in laparoscopic total extraperitoneal hernioplastyMelissa Shannon Chan, Chan Shannon Melissa, Anthony Yuen Bun Teoh, et al.Journal of Clinical Immunology|November 12, 2009
Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemiaPamela P W Lee, Tong-Xin Chen, Li-Ping Jiang, et al.Journal of Clinical Immunology|March 25, 2009
Clinical and molecular characteristics of 35 Chinese children with Wiskott-Aldrich syndromePamela P W Lee, Tong-Xin Chen, Li-Ping Jiang, et al.Frontiers in Immunology|January 22, 2025
Case report: A novel de novo germline loss-of-function mutation in the STAT1 transactivation domain in two Chinese siblings, with the elder sibling presenting with multifocal Bacillus Calmette-Guerin osteomyelitisQin Ying Lim, Daniel Leung, Crystal K Lam, et al.The Journal of Infectious Diseases|June 5, 2024
Seroepidemiology of Measles and Rubella Among Hong Kong Young Adults and the Humoral Responses of a Measles-Mumps-Rubella Booster Among Participants With Low Antibody LevelsJeffery C H Chan, Daniel Leung, Sau Man Chan, et al.JCI Insight|July 22, 2025
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathwayBo Zhang, Prajish Iyer, Meiling Jin, et al.Journal of Hepatology|August 28, 2013
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary teamJessica Dyson, Bryan Jaques, Dipankar Chattopadyhay, et al.Plos One|April 19, 2017
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitisStuart McPherson, Nina Wilkinson, Dina Tiniakos, et al.Pageof 34